Core Viewpoint - Wolf Haldenstein Adler Freeman & Herz LLP is investigating potential breaches of fiduciary duty by the Board of Directors and senior management of Semler Scientific Inc. related to securities fraud allegations [1][2]. Investigation Details - The investigation focuses on whether certain officers and/or directors of Semler have engaged in securities fraud [2]. - Semler disclosed in its Form 10-K filed on February 28, 2025, that it received a civil investigative demand from the U.S. Department of Justice (DOJ) in July 2017 regarding claims for reimbursement related to the QuantaFlo device [3]. - Subsequent requests for information from the DOJ occurred in February 2019, December 2021, April 2022, and April 2023, with unsuccessful settlement discussions taking place in February 2025 [3]. - There is a risk that the DOJ may file a complaint in a civil False Claims Act lawsuit seeking damages against Semler [3]. Firm Background - Wolf Haldenstein has extensive experience in prosecuting securities class actions and derivative litigation across state and federal courts [3]. - The firm is recognized for its expertise in shareholder and class litigation, having been appointed to significant positions in complex securities and multi-district litigation by the courts [3].

Previously, Natalie was an award-winning TV journalist and investigative reporter. For more than 10 years she covered in-depth local and national news topics and holds a regional news Emmy for breaking news coverage. "We are thrilled to welcome Natalie to our board of directors," said Eric Semler, chairman of Semler Scientific. "Natalie is a highly respected journalist and educator – and a leading advocate for Bitcoin, with a deep understanding of its role as a transformative asset. As the 4th largest U.S. ...

Core Viewpoint - Wolf Haldenstein Adler Freeman & Herz LLP is investigating claims on behalf of investors of Semler Scientific Inc. regarding potential securities fraud by the company and its officers and/or directors [1][2]. Investigation Details - The investigation is focused on whether Semler and certain officers and/or directors have engaged in securities fraud [2]. - Semler disclosed in its Form 10-K filed on February 28, 2025, that it received a civil investigative demand from the U.S. Department of Justice (DOJ) in July 2017 concerning claims for reimbursement related to the QuantaFlo device [3]. - The company has received multiple requests for information from the DOJ over the years, with the most recent being in April 2023 [3]. - In February 2025, Semler engaged in unsuccessful settlement discussions with the DOJ, which raises the risk of a potential civil False Claims Act lawsuit seeking damages [3]. Firm Background - Wolf Haldenstein has extensive experience in prosecuting securities class actions and derivative litigation in various courts across the United States [3]. - The firm is recognized for its expertise in shareholder and class litigation, having been appointed to significant positions in complex securities and multi-district litigation by the courts [3].

Financial Data and Key Metrics Changes - Total revenues in Q1 2025 were $8.8 million, down approximately 44% compared to Q1 2024 [15] - Operating expenses in Q1 2025 were $39.9 million, compared to $8.9 million in Q1 2024, including a $29.8 million contingency reserve related to a DOJ settlement [15] - The net loss for Q1 2025 was $64.7 million, or $6.74 per share, compared to a net income of $6.1 million, or $0.88 per share in Q1 2024 [18] Business Line Data and Key Metrics Changes - The healthcare business is experiencing pressure from payment changes made by CMS, impacting revenue [12] - The company is targeting growth in the cardiovascular space and plans to introduce additional FDA cleared products [12][25] Market Data and Key Metrics Changes - The company has acquired a total of 3,808 Bitcoins valued at approximately $400 million, making it the fourth largest Bitcoin treasury company in the US [6] - In 2025, the company acquired 1,510 Bitcoins with a BTC yield of 22.2%, resulting in a BTC dollar gain of $52 million [6] Company Strategy and Development Direction - The company prioritizes its Bitcoin treasury strategy while managing its healthcare business to generate cash for Bitcoin purchases [10] - The strategic focus includes diversifying the customer base and expanding into new markets with potentially life-saving products [25] Management's Comments on Operating Environment and Future Outlook - Management acknowledges headwinds in the healthcare business but sees opportunities for growth in the cardiovascular space [12] - The company aims to minimize declines in QuantiFlo revenue while maintaining infrastructure for innovation and growth [25] Other Important Information - The company completed a $100 million convertible note financing round, using most proceeds to buy Bitcoin [8] - A new $500 million ATM program became effective on April 22, 2025, to support Bitcoin acquisitions [8][20] Q&A Session Summary Question: What are your plans this year for accumulating more Bitcoin? - The company has ambitious plans to increase its Bitcoin stockpile and is confident in utilizing its $500 million ATM for additional acquisitions [23] Question: What's driving the underlying trends in the business, and what do you expect for 2025? - Despite government payment changes, the company continues to see testing and customer additions, focusing on minimizing revenue declines while expanding its product offerings [24][25]

Financial Data and Key Metrics Changes - Total revenues in Q1 2025 were $8.8 million, down approximately 44% compared to Q1 2024 [15] - Operating expenses in Q1 2025 were $39.9 million, compared to $8.9 million in Q1 2024, including a $29.8 million contingency reserve related to a DOJ settlement [15] - The net loss for Q1 2025 was $64.7 million, or $6.74 per share, compared to a net income of $6.1 million, or $0.88 per share in Q1 2024 [18] Business Line Data and Key Metrics Changes - The healthcare business is experiencing pressure from payment changes made by CMS, impacting revenue [12] - The company is targeting growth in the cardiovascular space and plans to introduce additional FDA cleared products [12][25] Market Data and Key Metrics Changes - The company has acquired a total of 3,808 Bitcoins valued at approximately $400 million, making it the fourth largest Bitcoin treasury company in the US [6] - In 2025, the company acquired 1,510 Bitcoins with a BTC yield of 22.2%, resulting in a BTC dollar gain of $52 million [6] Company Strategy and Development Direction - The company prioritizes its Bitcoin treasury strategy while managing its healthcare business to generate cash for Bitcoin purchases [10] - The strategic focus includes diversifying the customer base and innovating in the healthcare sector [12][25] Management's Comments on Operating Environment and Future Outlook - Management acknowledges headwinds in the healthcare business but sees potential for growth through new initiatives [12] - The company aims to minimize declines in QuantiFlo revenue while expanding into new markets [25] Other Important Information - The company launched a Bitcoin dashboard for investors to track Bitcoin-related statistics [21] - A new $500 million ATM program became effective on April 22, 2025, to support Bitcoin acquisitions [8] Q&A Session Summary Question: What are your plans this year for accumulating more Bitcoin? - The company has ambitious plans to increase its Bitcoin stockpile and is confident in utilizing its $500 million ATM for additional acquisitions [23] Question: What's driving the underlying trends in the business, and what do you expect for 2025? - Despite government payment changes, the company continues to see testing and customer additions, focusing on maintaining infrastructure for growth in cardiovascular disease states [24][25]

Financial Data and Key Metrics Changes - Total revenues in Q1 2025 were $8.8 million, down approximately 44% compared to Q1 2024 [13] - Operating expenses in Q1 2025 were $39.9 million, compared to $8.9 million in Q1 2024, including a $29.8 million contingency reserve related to a DOJ settlement [13] - The net loss for Q1 2025 was $64.7 million, or $6.74 per share, compared to a net income of $6.1 million, or $0.88 per share in Q1 2024 [15] Business Line Data and Key Metrics Changes - The healthcare business is experiencing pressure from payment changes made by CMS, but there are signs of growth in diversifying the customer base and introducing new FDA cleared products [11] - The company is pursuing a new 510(k) clearance for a product extension aimed at diagnosing heart failure, expected in 2025 [11] Market Data and Key Metrics Changes - The company has acquired a total of 3,808 Bitcoins valued at nearly $400 million, making it the fourth largest Bitcoin treasury company in the U.S. [6] - In 2025, the company acquired 1,510 Bitcoins with a yield of 22.2%, resulting in a BTC dollar gain of $52 million [6] Company Strategy and Development Direction - The corporate strategy is focused on three core principles: prioritizing the Bitcoin treasury strategy, ensuring the healthcare business generates cash, and increasing Bitcoin holdings [9] - The company aims to manage its healthcare business to generate cash primarily for Bitcoin purchases [4] Management's Comments on Operating Environment and Future Outlook - Management acknowledges headwinds in the healthcare business but remains optimistic about future growth opportunities in the cardiovascular space [11] - The company emphasizes its commitment to executing its Bitcoin treasury strategy alongside its healthcare business [24] Other Important Information - The company completed a $100 million convertible note financing round, using most proceeds to buy Bitcoin [7] - A new $500 million ATM program became effective on April 22, 2025, to support further Bitcoin acquisitions [7] Q&A Session Summary Question: What are your plans this year for accumulating more Bitcoin? - The company has ambitious plans to increase its Bitcoin stockpile and is confident in utilizing its $500 million ATM for additional acquisitions [21] Question: What's driving the underlying trends in the business, and what do you expect for 2025? - Despite government payment adjustments, the company is focused on minimizing declines in QuantiFlo revenue while expanding its customer base and targeting new markets [22][23]

The Semler Vision: Medical and Monetary Freedom Empowering Early Detection. Backed by Bitcoin. May 13, 2025 Forward-Looking Statements This presentation includes statements that are, or may be deemed, "forward-looking statements." In some cases, these forward-looking statements can be identified by the use of forward-looking terminology, including the terms "believe," "estimate," "anticipate," "expect," "plan," "intend," "may," "could," "might," "will," "should," or, in each case, their negative or other va ...

Financial Performance - Revenues for Q1 2025 were $8,835,000, a decrease of 44% compared to $15,903,000 in Q1 2024[23] - Net loss for Q1 2025 was $64,702,000, compared to a net income of $6,073,000 in Q1 2024, resulting in a basic net loss per share of $6.74[23] - Total operating expenses surged to $39,936,000 in Q1 2025, compared to $8,927,000 in Q1 2024, primarily due to a litigation contingency of $29,750,000[23] - For the three months ended March 31, 2025, total revenues were $8.8 million, a decrease of 44.2% compared to $15.9 million in the same period in 2024[128] - The net loss for the three months ended March 31, 2025, was $64.7 million, compared to a net income of $6.1 million in the same period in 2024[128] - Total operating expenses for the same period were $39.9 million, an increase of $31.0 million or 347% compared to $8.9 million in the prior year, with operating expenses as a percentage of revenues rising to 452%[138][139] Cash and Assets - Cash and cash equivalents increased to $9,737,000 as of March 31, 2025, up from $8,819,000 at the end of 2024[25] - Total assets rose to $293,445,000 as of March 31, 2025, compared to $239,828,000 at the end of 2024[25] - As of March 31, 2025, the Company held cash deposits of $6,195, which increased from $5,314 as of December 31, 2024[69] - The Company’s intangible digital assets increased to $263,504,000 as of March 31, 2025, compared to $214,633,000 at the end of 2024[25] - The fair value of the Company's intangible digital assets increased from $214,633 to $263,504 during the three months ended March 31, 2025, despite an unrealized loss of $41,829[65] Liabilities and Contingencies - Current liabilities increased significantly to $35,667,000 in Q1 2025, compared to $6,313,000 in Q4 2024[25] - The Company has a litigation contingency liability of $29,750 booked as of March 31, 2025, related to settlement discussions with the U.S. Department of Justice[97] - The company recorded a contingent liability of $29.8 million related to a proposed settlement with the DOJ as of March 31, 2025[135] - The company had negative working capital of approximately $17.2 million due to the contingent liability related to the DOJ settlement[147] Investments and Financing Activities - The company purchased digital assets worth $90,700,000 in Q1 2025, indicating a strategic investment in cryptocurrencies[30] - Proceeds from the issuance of debt amounted to $100,000,000 in Q1 2025, reflecting a significant financing activity[30] - The company generated $90.1 million of net cash from financing activities during the three months ended March 31, 2025, primarily from the issuance of 4.25% convertible senior notes[154] - The Company entered into a purchase agreement for the sale of $100,000 aggregate principal amount of 4.25% convertible senior notes due 2030 on January 28, 2025[77] - The Company issued 2030 Senior Notes with proceeds of approximately $95,984, net of debt issuance costs of $4,016[88] Stock and Shareholder Information - The Company has authorized 50,000,000 shares of common stock, with each share entitled to one vote[98] - As of March 31, 2025, the Company had issued and sold a total of 2,237,988 shares of common stock for aggregate gross proceeds of approximately $119,715[100] - The Company matched $97 and $64 for employee 401(k) deferrals for the three-month periods ended March 31, 2025, and 2024, respectively[95] - The initial conversion price of the 2030 Senior Notes is approximately $76.44 per share, representing a premium of about 25.0% over the last reported sale price of the Company's common stock on January 23, 2025[79] Bitcoin Holdings and Strategy - The Company held approximately 3,192 bitcoins with a cost basis of $280,400 and a fair value of $263,504 as of March 31, 2025[64] - The company reported a fair value of 2,298 bitcoins at $214.6 million as of December 31, 2024, compared to the current holdings[196] - The company anticipates that the proportion of total assets represented by bitcoin holdings will increase in the future, leading to greater earnings volatility[197] - The company's bitcoin treasury strategy exposes it to significant volatility, with bitcoin trading between $50,000 and $109,000 in the past year[173] - The company faces significant risks due to the concentration of its bitcoin holdings, which limits risk mitigation opportunities and could lead to pronounced impacts on financial condition with any significant declines in bitcoin prices[211] Regulatory and Compliance Issues - The company is subject to enhanced regulatory scrutiny regarding bitcoin-related transactions, which may impose additional compliance requirements[205] - The company faces risks from potential regulatory actions that could impact the price and transferability of bitcoin[186] - The emergence of alternative digital assets, including stablecoins and central bank digital currencies (CBDCs), could negatively impact the price of bitcoin and adversely affect the company's financial condition[215] - The company has not registered the notes or shares of common stock issuable upon conversion under the Securities Act, limiting their offer and sale in the U.S.[163] Accounting and Disclosure - The Company adopted ASU 2023-09 effective January 1, 2025, which requires enhanced disclosures surrounding income taxes[43] - The Company is currently evaluating the impact of new accounting guidance issued by FASB in November 2024 on its disclosures[41] - The adoption of ASU 2023-08 is expected to materially impact the company's financial results, increasing volatility and affecting the carrying value of bitcoin on the balance sheet[181] - The company maintains effective disclosure controls and procedures as of March 31, 2025, ensuring timely financial reporting[168]

Exhibit 99.1 "We continue to accretively grow our bitcoin arsenal using operating cash flow and proceeds from debt and equity financings," said Eric Semler, chairman of Semler Scientific. "And we are excited to launch the Semler Scientific dashboard today on our website to provide the public with regularly updated information on our bitcoin holdings and other key metrics." "Our healthcare business is seeing green shoots from the cardiovascular product line that we introduced to our large enterprise customer ...

SANTA CLARA, Calif., April 25, 2025 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a pioneer in developing and marketing technology products and services to assist its customers in evaluating and treating chronic diseases, today announced updates regarding its bitcoin (BTC) activity, holdings and yield, as well as its at-the-market equity offering (ATM) programs. BTC Update Between February 14, 2025 and April 24, 2025, Semler Scientific acquired 111 bitcoins for $10.0 million with an average purcha ...